Potent Anticancer Effects of Lentivirus Encoding a Drosophila Melanogaster Deoxyribonucleoside Kinase Mutant Combined with Brivudine |
Zhang, Nian-Qu
(Department of Surgical Oncology, Department of General Surgery, First Affiliated Hospital, China Medical University)
Zhao, Lei (Center of Experiment Technology and Medical Research, China Medical University) Ma, Shuai (Department of Surgical Oncology, Department of General Surgery, First Affiliated Hospital, China Medical University) Gu, Ming (Department of Surgical Oncology, Department of General Surgery, First Affiliated Hospital, China Medical University) Zheng, Xin-Yu (Department of Surgical Oncology, Department of General Surgery, First Affiliated Hospital, China Medical University) |
1 | Caruso M, Panis Y, Gagandeep S, et al (1993). Regression of established macroscopic live metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA, 90, 7024-8. DOI ScienceOn |
2 | Eichholz A, Merchant S, Gaya AM (2010). Anti-angiogenesis therapies: their potential in cancer management. Onco Targets Ther, 3, 69-82. |
3 | Gerber DE (2008). Targeted therapies: a new generation of cancer treatments. Am Fam Physician, 77, 311-9. |
4 | Ito M, Suda Y, Harashima H, Kamiya H (2010). Cytotoxic effect of Drosophila deoxynucleoside kinase gene on replicating plasmid in HeLa cells. Biol Pharm Bull, 33, 1223-7. DOI |
5 | Johansson M, van Rompay AR, Degreve B, Balzarini J, Karlsson A (1999). Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster. J Biol Chem, 274, 23814-9. DOI |
6 | Kamizono J, Nagano S, Murofushi Y, et al (2005). Survivinresponsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication. Cancer Res, 65, 5284-91. DOI |
7 | Kianmanesh AR, Perrin H, Panis Y, et al (1997). A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum Gene Ther, 8, 1807-14. DOI |
8 | Knecht W, Mikkelsen NE, Clausen AR, et al (2009). Drosophila melanogaster deoxyribonucleoside kinase activates gemcitabine. Biochem Biophys Res Commun, 382, 430-3. DOI |
9 | Knecht W, Sandrini MP, Johansson K, et al (2002). A few amino acid substitutions can convert deoxyribonucleoside kinase specificity from pyrimidines to purines. EMBO J, 21, 1873-80. DOI |
10 | Ma S, Qu W, Mao L, et al (2012). Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer. Oncol Rep, 27, 1443-50. |
11 | Ma S, Zhao L, Zhu Z, et al (2011). The multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster as a therapeutic suicide gene of breast cancer cells. J Gene Med, 13, 305-11. |
12 | Munch-Petersen B, Knecht W, Lenz C, Sondergaard L, Piskur J (2000). Functional expression of a multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants. J Biol Chem, 275, 6673-9. DOI |
13 | Munch-Petersen B, Piskur J, Sondergaard L (1998a). Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase. J Biol Chem, 273, 3926-31. DOI |
14 | Sandrini MP, Clausen AR, On SL, et al (2007). Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner. J Antimicrob Chemother, 60, 510-20. DOI |
15 | Munch-Petersen B, Piskur J, Sondergaard L (1998b). The single deoxynucleoside kinase in Drosophila melanogaster, Dm-dNK, is multifunctional and differs from the mammalian deoxynucleoside kinases. Adv Exp Med Biol, 431, 465-9. DOI |
16 | Nettelbeck DM, Rivera AA, Balague C, Alemany R, Curiel DT (2002). Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/ promoter. Cancer Res, 62, 4663-70. |
17 | Okabe S, Arai T, Yamashita H, Sugihara K (2003). Adenovirus-mediated prodrug-enzyme therapy for CEAproducing colorectal cancer cells. J Cancer Res Clin Oncol, 129, 367-73. DOI |
18 | Solaroli N, Bjerke M, Amiri MH, Johansson M, Karlsson A (2003). Active site mutants of Drosophila melanogaster multisubstrate deoxyribonucleoside kinase. Eur J Biochem, 270, 2879-84. DOI |
19 | Solaroli N, Johansson M, Balzarini J, Karlsson A (2007). Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants. Gene Therapy, 14, 86-92. DOI |
20 | Springer CJ, Niculescu-Duvaz I (2000). Prodrug-activating systems in suicide gene therapy. JJ Clin Invest, 105, 1161-7. DOI |
21 | Springett GM, Moen RC, Anderson S, Blaese RM, Anderson WF (1989). Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol, 63, 3865-9. |
22 | Zheng X, Johansson M, Karlsson A (2000). Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase. J Biol Chem, 275, 39125-9. DOI |
23 | Zhu Z, Mao L, Zhao L, et al (2011b). Synergistic therapeutic effect in gastric cancer cells produced by oncolytic adenovirus encoding Drosophila melanogaster deoxyribonucleoside kinase. Cancer Biol Ther, 11, 874-82. DOI |
24 | Zheng X, Johansson M, Karlsson A (2001a). Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea. Mol Pharmacol, 60, 262-6. DOI |
25 | Zheng X, Johansson M, Karlsson A (2001b). Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol. Biochem Biophys Res Commun, 289, 229-33. DOI |
26 | Zhu Z, Ma S, Zhao L, et al (2011a). Adenovirus-mediated Drosophila melanogaster deoxyribonucleoside kinase mutants combined with gemcitabine harbor a safe cancer treatment profile. Int J Oncol, 38, 745-53. |
![]() |